ad

3 Exhibition Centre Operator, Solar Modules Maker and Diagnostics Services Company Stocks With a Strong Future Roadmap: Nesco, Waaree Energies and Krsnaa Diagnostics

Nesco, Waaree Energies and Krsnaa Diagnostics: ROE of 10.3% to 25.7% and FY22 to FY26 revenue CAGR of 14.8% to 74.3%. Prices as of 13 Nov 2026.


16 Nov 2026 • 2:19 pm

3 Exhibition Centre Operator, Solar Modules Maker and Diagnostics Services Company Stocks With a Strong Future Roadmap: Nesco, Waaree Energies and Krsnaa Diagnostics

Quick Answer

The three exhibition venue, solar module and lab stocks to watch are Nesco, Waaree Energies and Krsnaa Diagnostics. Their return on equity ranges from 10.3% to 25.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.8% to 74.3%. Waaree Energies leads on both return on equity at 25.7% and revenue growth at 74.3% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.

Exhibition venue, solar module and lab stocks let investors follow companies that serve a growing part of the Indian economy. Nesco, Waaree Energies and Krsnaa Diagnostics cover an exhibition centre operator, a solar modules maker and a diagnostics services company.

This list covers three exhibition venue, solar module and lab stocks with complete current figures: Nesco, Waaree Energies and Krsnaa Diagnostics. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Exhibition Venue, Solar Module and Lab Stocks?

Exhibition venue, solar module and lab stocks are listed companies that run large exhibition and convention centres and a hotel, make solar cells and modules for power projects and homes, and run diagnostic labs for public and private clients. Their earnings depend on event bookings, solar installations and test volumes.

Exhibition Venue, Solar Module and Lab Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Nesco 1,054.7 7,098 17.0 30.7 13.8 0.09
Waaree Energies 2,546 72,290 18.1 43.9 25.7 0.22
Krsnaa Diagnostics 528.75 1,615 16.6 58.4 10.3 0.55

On valuation, all three trade at a P/E below their industry P/E, which means the market is pricing them at a lower multiple than their peer group. Readers comparing exhibition venue, solar module and lab stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Exhibition Venue, Solar Module and Lab Stocks Have a Strong Roadmap in India?

Exhibition venue, solar module and lab stocks have a strong roadmap in India because growing trade shows and events, fast growth of solar installations and wider use of preventive tests keep widening the market for these companies.

  • Exhibition venues. Businesses host more events.
  • Solar modules. Power projects need more solar capacity.
  • Diagnostics. Families test more for preventive care.

Why Nesco Features Among These Exhibition Venue, Solar Module and Lab Stocks

Among the exhibition venue, solar module and lab stocks on this list, Nesco owns and operates the Bombay Exhibition Centre in Mumbai, one of India's large venues for trade shows and events, along with an IT park and a hospitality business.

In the June 2026 quarter, revenue grew 15.3% year on year to Rs 255 crore, while net profit rose 4.0% to Rs 100.0 crore. Revenue rose from Rs 382 crore in FY22 to Rs 1,038 crore in FY26, a compound annual growth rate of 28.3%.

Net profit grew from Rs 189 crore in FY22 to Rs 413 crore in FY26, which works out to a compound annual growth rate of 21.5%. The company has a return on equity of 13.8%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 7,098 crore. The stock trades at a P/E of 17.0, below the industry P/E of 30.7.

Roadmap: The company earns steadily from exhibition and event bookings and from leased office space. Its prime Mumbai location and large facilities attract a wide mix of organisers and tenants.

What to watch: Follow event calendar bookings and occupancy at the IT park.

Why Waaree Energies Features Among These Exhibition Venue, Solar Module and Lab Stocks

Among the convention centre, solar cell and pathology shares on this list, Waaree Energies is one of India's largest manufacturers of solar photovoltaic modules, with factories in Gujarat, and it also provides solar project engineering and has expanded into cells and related products.

The company has a return on equity of 25.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 72,290 crore. The stock trades at a P/E of 18.1, below the industry P/E of 43.9.

Revenue rose from Rs 2,951 crore in FY22 to Rs 27,245 crore in FY26, a compound annual growth rate of 74.3%. Net profit grew from Rs 1,274 crore in FY24 to Rs 3,884 crore in FY26, which works out to a compound annual growth rate of 74.6%.

Roadmap: The company is adding module, cell and wafer capacity to build a deeper in-house supply chain, in line with domestic manufacturing incentives and rapid growth in solar installations. A strong order book from domestic and overseas customers supports volumes.

What to watch: Track the commissioning of new cell and module capacity and the order book for the coming quarters.

Why Krsnaa Diagnostics Features Among These Exhibition Venue, Solar Module and Lab Stocks

Among the three companies on this list, Krsnaa Diagnostics provides radiology and pathology services through partnerships with government hospitals and through its own diagnostic centres across many states.

Revenue rose from Rs 470 crore in FY22 to Rs 816 crore in FY26, a compound annual growth rate of 14.8%. Net profit grew from Rs 68.4 crore in FY22 to Rs 101 crore in FY26, which works out to a compound annual growth rate of 10.4%.

In the June 2026 quarter, revenue grew 23.3% year on year to Rs 243 crore. The company has a return on equity of 10.3%, a debt to equity ratio of 0.55 and a market capitalisation of Rs 1,615 crore. The stock trades at a P/E of 16.6, below the industry P/E of 58.4.

Roadmap: The company is winning new public sector contracts and adding advanced imaging services, which widens its patient reach. Growing demand for affordable diagnostics supports volumes.

What to watch: Track new contract wins, test volumes and the rollout of advanced imaging.

Nesco vs Waaree Energies vs Krsnaa Diagnostics on Key Financials

The table below sets the three exhibition venue, solar module and lab stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Nesco 382 1,038 28.3% 413 39.8%
Waaree Energies 2,951 27,245 74.3% 3,884 14.3%
Krsnaa Diagnostics 470 816 14.8% 101 12.4%

Waaree Energies posts the highest return on equity in this group at 25.7%. Waaree Energies combines the largest FY26 revenue at Rs 27,245 crore with the fastest revenue growth, a 74.3% compound annual rate. A useful habit with exhibition venue, solar module and lab stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Exhibition Venue, Solar Module and Lab Stocks

Every theme carries risks that deserve a check before any decision. For these exhibition venue, solar module and lab stocks, the main points are: Long-term convention centre, solar cell and pathology shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Travel cycles. Bookings and occupancy follow travel demand.
  • Module prices. Solar equipment prices and policy support can change returns.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter exhibition venue, solar module and lab stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Exhibition Venue, Solar Module and Lab Stocks

Exhibition venue, solar module and lab stocks reward investors who follow demand trends, order books and margins together. Nesco, Waaree Energies and Krsnaa Diagnostics each have a clear plan to grow. Based on the 13 November 2026 close, Nesco trades at Rs 1,054.7, Waaree Energies at Rs 2,546 and Krsnaa Diagnostics at Rs 528.75.

Download the Univest iOS App or Univest Android App to track exhibition venue, solar module and lab stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are exhibition venue, solar module and lab stocks?

Ans. Exhibition venue, solar module and lab stocks are listed companies that run large exhibition and convention centres and a hotel, make solar cells and modules for power projects and homes, and run diagnostic labs for public and private clients. Their earnings depend on event bookings, solar installations and test volumes. This list looks at three of them, Nesco, Waaree Energies and Krsnaa Diagnostics, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.

Which exhibition venue, solar module and lab stocks are covered in this list?

Ans. This list covers Nesco, Waaree Energies and Krsnaa Diagnostics. Based on the 13 November 2026 close, Nesco traded at Rs 1,054.7, Waaree Energies at Rs 2,546 and Krsnaa Diagnostics at Rs 528.75. Their return on equity ranges from 10.3% to 25.7%, and their revenue compound annual growth from FY22 to FY26 ranges from 14.8% to 74.3%.

Why do exhibition venue, solar module and lab stocks have a strong future roadmap in India?

Ans. Exhibition venue, solar module and lab stocks have a strong roadmap in India because growing trade shows and events, fast growth of solar installations and wider use of preventive tests keep widening the market for these companies. The main drivers are as follows. Exhibition venues. Businesses host more events. Solar modules. Power projects need more solar capacity. Diagnostics. Families test more for preventive care. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Nesco performed financially?

Ans. Revenue rose from Rs 382 crore in FY22 to Rs 1,038 crore in FY26, a compound annual growth rate of 28.3%. Net profit grew from Rs 189 crore in FY22 to Rs 413 crore in FY26, which works out to a compound annual growth rate of 21.5%. In the June 2026 quarter, revenue grew 15.3% year on year to Rs 255 crore, while net profit rose 4.0% to Rs 100.0 crore. The company has a return on equity of 13.8%, a debt to equity ratio of 0.09 and a market capitalisation of Rs 7,098 crore. The stock trades at a P/E of 17.0, below the industry P/E of 30.7. Looking ahead, the company earns steadily from exhibition and event bookings and from leased office space. Its prime Mumbai location and large facilities attract a wide mix of organisers and tenants.

How has Waaree Energies performed financially?

Ans. Revenue rose from Rs 2,951 crore in FY22 to Rs 27,245 crore in FY26, a compound annual growth rate of 74.3%. Net profit grew from Rs 1,274 crore in FY24 to Rs 3,884 crore in FY26, which works out to a compound annual growth rate of 74.6%. The company has a return on equity of 25.7%, a debt to equity ratio of 0.22 and a market capitalisation of Rs 72,290 crore. The stock trades at a P/E of 18.1, below the industry P/E of 43.9. Looking ahead, the company is adding module, cell and wafer capacity to build a deeper in-house supply chain, in line with domestic manufacturing incentives and rapid growth in solar installations. A strong order book from domestic and overseas customers supports volumes.

How has Krsnaa Diagnostics performed financially?

Ans. Revenue rose from Rs 470 crore in FY22 to Rs 816 crore in FY26, a compound annual growth rate of 14.8%. Net profit grew from Rs 68.4 crore in FY22 to Rs 101 crore in FY26, which works out to a compound annual growth rate of 10.4%. In the June 2026 quarter, revenue grew 23.3% year on year to Rs 243 crore. The company has a return on equity of 10.3%, a debt to equity ratio of 0.55 and a market capitalisation of Rs 1,615 crore. The stock trades at a P/E of 16.6, below the industry P/E of 58.4. Looking ahead, the company is winning new public sector contracts and adding advanced imaging services, which widens its patient reach. Growing demand for affordable diagnostics supports volumes.

What risks should investors check before buying exhibition venue, solar module and lab stocks?

Ans. Investors should check a few risks before buying exhibition venue, solar module and lab stocks. Travel cycles. Bookings and occupancy follow travel demand. Module prices. Solar equipment prices and policy support can change returns. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of exhibition venue, solar module and lab stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down